Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey
- 1 March 2009
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 58 (3) , 238-244
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Crimean?Congo hemorrhagic feverAntiviral Research, 2004
- Characteristics of Patients with Crimean-Congo Hemorrhagic Fever in a Recent Outbreak in Turkey and Impact of Oral Ribavirin TherapyClinical Infectious Diseases, 2004
- SHORT REPORT: CRIMEAN-CONGO HEMORRHAGIC FEVER OUTBREAK IN RAWALPINDI, PAKISTAN, FEBRUARY 2002The American Journal of Tropical Medicine and Hygiene, 2003
- Quantitative Real-Time PCR Detection of Rift Valley Fever Virus and Its Application to Evaluation of Antiviral CompoundsJournal of Clinical Microbiology, 2001
- Crimean Congo-Haemorrhagic Fever treated with oral ribavirinThe Lancet, 1995
- Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infectionAntiviral Research, 1993
- Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal SyndromeThe Journal of Infectious Diseases, 1991
- Inhibition of Crimean-Congo Hemorrhagic Fever Viral Infectivity Yields in Vitro by RibavirinThe American Journal of Tropical Medicine and Hygiene, 1989
- Prospects for Treatment of Viral Hemorrhagic Fevers with Ribavirin, a Broad-Spectrum Antiviral DrugClinical Infectious Diseases, 1989
- Lassa FeverNew England Journal of Medicine, 1986